SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC. - Peters S; Hochmair M; Arbour KC; Rodriguez LP; Reck M; Leal T; R Lindsay C; Shun L; William WN; Spira AI; Sabari JK; Henning Grønberg B; et al. (Future oncology (London, England), 2026)